Gene	Gene synonym	Ensembl	Gene description	Uniprot	Chromosome	Position	Protein class	Biological process	Molecular function	Disease involvement	Evidence	HPA evidence	UniProt evidence	NeXtProt evidence	MS evidence	RNA tissue specificity	RNA tissue distribution	RNA tissue specificity score	RNA tissue specific NX	RNA single cell type specificity	RNA single cell type distribution	RNA single cell type specificity score	RNA single cell type specific NX	RNA cancer specificity	RNA cancer distribution	RNA cancer specificity score	RNA cancer specific FPKM	RNA brain regional specificity	RNA brain regional distribution	RNA brain regional specificity score	RNA brain regional specific NX	RNA blood cell specificity	RNA blood cell distribution	RNA blood cell specificity score	RNA blood cell specific NX	RNA blood lineage specificity	RNA blood lineage distribution	RNA blood lineage specificity score	RNA blood lineage specific NX	RNA cell line specificity	RNA cell line distribution	RNA cell line specificity score	RNA cell line specific NX	RNA mouse brain regional specificity	RNA mouse brain regional distribution	RNA mouse brain regional specificity score	RNA mouse brain regional specific pTPM	RNA pig brain regional specificity	RNA pig brain regional distribution	RNA pig brain regional specificity score	RNA pig brain regional specific pTPM	Antibody	Reliability (IH)	Reliability (Mouse Brain)	Reliability (IF)	Subcellular location	Secretome location	CCD Protein	CCD Transcript	Blood concentration - Conc. blood IM [pg/L]	Blood concentration - Conc. blood MS [pg/L]	Subcellular main location	Subcellular additional location	Antibody RRID	Pathology prognostics - Breast cancer	Pathology prognostics - Cervical cancer	Pathology prognostics - Colorectal cancer	Pathology prognostics - Endometrial cancer	Pathology prognostics - Glioma	Pathology prognostics - Head and neck cancer	Pathology prognostics - Liver cancer	Pathology prognostics - Lung cancer	Pathology prognostics - Melanoma	Pathology prognostics - Ovarian cancer	Pathology prognostics - Pancreatic cancer	Pathology prognostics - Prostate cancer	Pathology prognostics - Renal cancer	Pathology prognostics - Stomach cancer	Pathology prognostics - Testis cancer	Pathology prognostics - Thyroid cancer	Pathology prognostics - Urothelial cancer	Tissue RNA - adipose tissue [NX]	Tissue RNA - adrenal gland [NX]	Tissue RNA - amygdala [NX]	Tissue RNA - appendix [NX]	Tissue RNA - basal ganglia [NX]	Tissue RNA - bone marrow [NX]	Tissue RNA - breast [NX]	Tissue RNA - cerebellum [NX]	Tissue RNA - cerebral cortex [NX]	Tissue RNA - cervix, uterine [NX]	Tissue RNA - colon [NX]	Tissue RNA - corpus callosum [NX]	Tissue RNA - ductus deferens [NX]	Tissue RNA - duodenum [NX]	Tissue RNA - endometrium 1 [NX]	Tissue RNA - epididymis [NX]	Tissue RNA - esophagus [NX]	Tissue RNA - fallopian tube [NX]	Tissue RNA - gallbladder [NX]	Tissue RNA - heart muscle [NX]	Tissue RNA - hippocampal formation [NX]	Tissue RNA - hypothalamus [NX]	Tissue RNA - kidney [NX]	Tissue RNA - liver [NX]	Tissue RNA - lung [NX]	Tissue RNA - lymph node [NX]	Tissue RNA - midbrain [NX]	Tissue RNA - olfactory region [NX]	Tissue RNA - ovary [NX]	Tissue RNA - pancreas [NX]	Tissue RNA - parathyroid gland [NX]	Tissue RNA - pituitary gland [NX]	Tissue RNA - placenta [NX]	Tissue RNA - pons and medulla [NX]	Tissue RNA - prostate [NX]	Tissue RNA - rectum [NX]	Tissue RNA - retina [NX]	Tissue RNA - salivary gland [NX]	Tissue RNA - seminal vesicle [NX]	Tissue RNA - skeletal muscle [NX]	Tissue RNA - skin 1 [NX]	Tissue RNA - small intestine [NX]	Tissue RNA - smooth muscle [NX]	Tissue RNA - spinal cord [NX]	Tissue RNA - spleen [NX]	Tissue RNA - stomach 1 [NX]	Tissue RNA - testis [NX]	Tissue RNA - thalamus [NX]	Tissue RNA - thymus [NX]	Tissue RNA - thyroid gland [NX]	Tissue RNA - tongue [NX]	Tissue RNA - tonsil [NX]	Tissue RNA - urinary bladder [NX]	Tissue RNA - vagina [NX]	Tissue RNA - B-cells [NX]	Tissue RNA - dendritic cells [NX]	Tissue RNA - granulocytes [NX]	Tissue RNA - monocytes [NX]	Tissue RNA - NK-cells [NX]	Tissue RNA - T-cells [NX]	Tissue RNA - total PBMC [NX]	Cell RNA - A-431 [NX]	Cell RNA - A549 [NX]	Cell RNA - AF22 [NX]	Cell RNA - AN3-CA [NX]	Cell RNA - ASC diff [NX]	Cell RNA - ASC TERT1 [NX]	Cell RNA - BEWO [NX]	Cell RNA - BJ [NX]	Cell RNA - BJ hTERT+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]	Cell RNA - CACO-2 [NX]	Cell RNA - CAPAN-2 [NX]	Cell RNA - Daudi [NX]	Cell RNA - EFO-21 [NX]	Cell RNA - fHDF/TERT166 [NX]	Cell RNA - GAMG [NX]	Cell RNA - HaCaT [NX]	Cell RNA - HAP1 [NX]	Cell RNA - HBEC3-KT [NX]	Cell RNA - HBF TERT88 [NX]	Cell RNA - HDLM-2 [NX]	Cell RNA - HEK 293 [NX]	Cell RNA - HEL [NX]	Cell RNA - HeLa [NX]	Cell RNA - Hep G2 [NX]	Cell RNA - HHSteC [NX]	Cell RNA - HL-60 [NX]	Cell RNA - HMC-1 [NX]	Cell RNA - HSkMC [NX]	Cell RNA - hTCEpi [NX]	Cell RNA - hTEC/SVTERT24-B [NX]	Cell RNA - hTERT-HME1 [NX]	Cell RNA - hTERT-RPE1 [NX]	Cell RNA - HUVEC TERT2 [NX]	Cell RNA - JURKAT [NX]	Cell RNA - K-562 [NX]	Cell RNA - Karpas-707 [NX]	Cell RNA - LHCN-M2 [NX]	Cell RNA - MCF7 [NX]	Cell RNA - MOLT-4 [NX]	Cell RNA - NB-4 [NX]	Cell RNA - NTERA-2 [NX]	Cell RNA - OE19 [NX]	Cell RNA - PC-3 [NX]	Cell RNA - REH [NX]	Cell RNA - RH-30 [NX]	Cell RNA - RPMI-8226 [NX]	Cell RNA - RPTEC TERT1 [NX]	Cell RNA - RT4 [NX]	Cell RNA - SCLC-21H [NX]	Cell RNA - SH-SY5Y [NX]	Cell RNA - SiHa [NX]	Cell RNA - SK-BR-3 [NX]	Cell RNA - SK-MEL-30 [NX]	Cell RNA - SuSa [NX]	Cell RNA - T-47d [NX]	Cell RNA - THP-1 [NX]	Cell RNA - TIME [NX]	Cell RNA - U-138 MG [NX]	Cell RNA - U-2 OS [NX]	Cell RNA - U-2197 [NX]	Cell RNA - U-251 MG [NX]	Cell RNA - U-266/70 [NX]	Cell RNA - U-266/84 [NX]	Cell RNA - U-698 [NX]	Cell RNA - U-87 MG [NX]	Cell RNA - U-937 [NX]	Cell RNA - WM-115 [NX]	Blood RNA - basophil [NX]	Blood RNA - classical monocyte [NX]	Blood RNA - eosinophil [NX]	Blood RNA - gdT-cell [NX]	Blood RNA - intermediate monocyte [NX]	Blood RNA - MAIT T-cell [NX]	Blood RNA - memory B-cell [NX]	Blood RNA - memory CD4 T-cell [NX]	Blood RNA - memory CD8 T-cell [NX]	Blood RNA - myeloid DC [NX]	Blood RNA - naive B-cell [NX]	Blood RNA - naive CD4 T-cell [NX]	Blood RNA - naive CD8 T-cell [NX]	Blood RNA - neutrophil [NX]	Blood RNA - NK-cell [NX]	Blood RNA - non-classical monocyte [NX]	Blood RNA - plasmacytoid DC [NX]	Blood RNA - T-reg [NX]	Blood RNA - total PBMC [NX]	Brain RNA - amygdala [NX]	Brain RNA - basal ganglia [NX]	Brain RNA - cerebellum [NX]	Brain RNA - cerebral cortex [NX]	Brain RNA - hippocampal formation [NX]	Brain RNA - hypothalamus [NX]	Brain RNA - midbrain [NX]	Brain RNA - olfactory region [NX]	Brain RNA - pons and medulla [NX]	Brain RNA - thalamus [NX]	Single Cell Type RNA - Alveolar cells type 1 [NX]	Single Cell Type RNA - Alveolar cells type 2 [NX]	Single Cell Type RNA - B-cells [NX]	Single Cell Type RNA - Basal glandular cells [NX]	Single Cell Type RNA - Basal keratinocytes [NX]	Single Cell Type RNA - Bipolar cells [NX]	Single Cell Type RNA - Cardiomyocytes [NX]	Single Cell Type RNA - Cholangiocytes [NX]	Single Cell Type RNA - Ciliated cells [NX]	Single Cell Type RNA - Club cells [NX]	Single Cell Type RNA - Collecting duct cells [NX]	Single Cell Type RNA - Cone photoreceptor cells [NX]	Single Cell Type RNA - Cytotrophoblasts [NX]	Single Cell Type RNA - Distal tubular cells [NX]	Single Cell Type RNA - Ductal cells [NX]	Single Cell Type RNA - Early spermatids [NX]	Single Cell Type RNA - Endothelial cells [NX]	Single Cell Type RNA - Enterocytes [NX]	Single Cell Type RNA - Erythroid cells [NX]	Single Cell Type RNA - Exocrine glandular cells [NX]	Single Cell Type RNA - Extravillous trophoblasts [NX]	Single Cell Type RNA - Fibroblasts [NX]	Single Cell Type RNA - Glandular cells [NX]	Single Cell Type RNA - granulocytes [NX]	Single Cell Type RNA - Hepatocytes [NX]	Single Cell Type RNA - Hofbauer cells [NX]	Single Cell Type RNA - Horizontal cells [NX]	Single Cell Type RNA - Intestinal endocrine cells [NX]	Single Cell Type RNA - Ito cells [NX]	Single Cell Type RNA - Kupffer cells [NX]	Single Cell Type RNA - Late spermatids [NX]	Single Cell Type RNA - Leydig cells [NX]	Single Cell Type RNA - Macrophages [NX]	Single Cell Type RNA - Melanocytes [NX]	Single Cell Type RNA - monocytes [NX]	Single Cell Type RNA - Mucus-secreting cells [NX]	Single Cell Type RNA - Muller glia cells [NX]	Single Cell Type RNA - Pancreatic endocrine cells [NX]	Single Cell Type RNA - Paneth cells [NX]	Single Cell Type RNA - Peritubular cells [NX]	Single Cell Type RNA - Proximal tubular cells [NX]	Single Cell Type RNA - Rod photoreceptor cells [NX]	Single Cell Type RNA - Sertoli cells [NX]	Single Cell Type RNA - Smooth muscle cells [NX]	Single Cell Type RNA - Spermatocytes [NX]	Single Cell Type RNA - Spermatogonia [NX]	Single Cell Type RNA - Suprabasal keratinocytes [NX]	Single Cell Type RNA - Syncytiotrophoblasts [NX]	Single Cell Type RNA - T-cells [NX]	Single Cell Type RNA - Undifferentiated cells [NX]	Single Cell Type RNA - Urothelial cells [NX]	RNAsingleCellTypeSpecific
IGF1	IGF-I, IGF1A, IGFI	ENSG00000017427	Insulin like growth factor 1	P05019	12	102395874-102481744	Disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins		Growth factor	Deafness	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	5	Leydig cells: 1021.5	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Group enriched	Detected in some	7	memory B-cell: 2.4;naive B-cell: 4.5	Lineage enriched	Detected in single	9	B-cells: 4.5	Cell line enhanced	Detected in some		ASC diff: 21.8;HDLM-2: 28.4;K-562: 12.7;Karpas-707: 6.8;U-266/70: 8.1	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA048946	Approved				Secreted to blood			103000000	410000000			HPA048946: AB_2680566	unprognostic (1.25e-1)	unprognostic (2.86e-3)	unprognostic (1.46e-1)	prognostic favorable (1.04e-4)	unprognostic (1.52e-1)	unprognostic (2.10e-1)	unprognostic (1.59e-3)	unprognostic (2.26e-1)	unprognostic (9.98e-2)	unprognostic (1.30e-1)	unprognostic (1.59e-1)	unprognostic (1.04e-2)	unprognostic (2.34e-1)	unprognostic (2.04e-2)	unprognostic (1.55e-1)	unprognostic (2.07e-1)	unprognostic (1.11e-3)	33.4	3.6	0.8	10.7	1.4	0.3	23	0.6	2.1	46.6	6.7	0.6	20.6	2.2	35	58.3	16.1	8.1	8.8	17.4	1.5	1	3.9	32.8	7.6	13.3	0.9	0.4	17.6	3.2	1.2	1.2	13.5	1.9	57.2	2.8	3.7	5.4	32	11.9	3.2	3.5	29.4	1	4.9	5.9	19	0.2	1.5	29.3	11.6	2.2	21.2	15.3	4.5	0.2	0.5	0.1	0.2	0.1	0.8	0.2	0	0	0	21.8	0	0.1	0.1	0	0	0	0.4	0	0	0	0	0	0	0	0	0	28.4	0	0	0.3	0	0.1	0	0	0.3	0	0	0	0	0	0	12.7	6.8	0	0	0	0.1	0	0	0	0	0	0.9	0	0	0.1	0.1	0.9	0	0.2	0.1	0	0	0	0	0	0	0	8.1	0.6	0	0	0	0	0.2	0.1	0.2	0.1	0	0.1	2.4	0.1	0.1	0	4.5	0.1	0.1	0.5	0.2	0.1	0.2	0	0.8	0.8	1.4	0.6	2.1	1.5	1	0.9	0.4	1.9	0.2	3	2.1	0	0.5	2.3	186.6	0.3	5.1	0	1.2	0	0	0.8	0	0	10.2	5.2	0	0	0.5	2.2	63.7	1.2	0	167.4	91.5	0	0	4.3	14.4	22.9	1021.5	9.8	13.5	6.4	0	2.1	0.1	0	181.8	1	7	0	3.3	1.6	1	2.4	1	2.9	0	0.1	Leydig cells
WISP2	CCN5, CT58, CTGF-L	ENSG00000064205	WNT1 inducible signaling pathway protein 2	O76076	20	44714844-44728509	Plasma proteins, Predicted secreted proteins	Cell adhesion			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		cervix, uterine: 109.7	Cell type enriched	Detected in many	12	Leydig cells: 367.7	Cancer enhanced	Detected in many		melanoma: 8.8	Low region specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		ASC diff: 10.0;ASC TERT1: 26.9;HeLa: 15.0;HSkMC: 10.9;U-2197: 85.9	Not detected	Not detected			Low region specificity	Detected in all			CAB019273	Approved				Secreted to extracellular matrix				400000			CAB019273: 	unprognostic (1.87e-1)	unprognostic (2.64e-1)	unprognostic (3.01e-2)	unprognostic (1.12e-1)	unprognostic (1.70e-1)	unprognostic (2.83e-1)	unprognostic (1.83e-1)	unprognostic (1.85e-1)	unprognostic (2.53e-1)	unprognostic (9.42e-2)	unprognostic (2.81e-1)	unprognostic (7.95e-3)	unprognostic (1.76e-10)	unprognostic (1.55e-3)	unprognostic (7.21e-2)	unprognostic (4.84e-2)	unprognostic (1.28e-1)	57	6.5	0.2	2	2.2	0.4	32.7	0.1	0.5	109.7	4.7	0.6	8.6	0.6	7	12.4	47.1	5.5	8.4	29.7	0.3	0	0.5	0.9	25.6	0.9	0.1	1.4	48.4	1.8	0.7	0	0.9	0.2	20.1	0.9	0.5	4.3	8.9	18	30.6	1.4	22	0.2	0.5	1.4	37.7	0.4	0	2.5	3.7	0.6	18.2	18.7	0	0	0	0	0.1	0	0	0	0.9	0	0	10	26.9	0	0	0.3	0	0	0	0	0	0.1	0.1	0.8	0	0	0	0	0	0	0	15	0	0	0	0	10.9	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.2	0	0	0.4	0	0	0	0	85.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.2	2.2	0.1	0.5	0.3	0	0.1	1.4	0.2	0.4	0	2.2	0	1.3	28.4	0.2	7.5	0	0	0	0	0	0	0	0	1.6	1.9	0	0	0	0	14.4	1.3	0	0	0.1	0	0	25.8	0.8	4	367.7	1.5	23.6	0	0	2	0.2	0	30.1	0	0	12.9	24.7	1.7	0.8	19.6	0	0	0	2	Leydig cells
HSD17B3	SDR12C2	ENSG00000130948	Hydroxysteroid 17-beta dehydrogenase 3	P37058	9	96235306-96302152	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins	Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis	Oxidoreductase	Disease mutation, Pseudohermaphroditism	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	testis: 41.9	Cell type enriched	Detected in some	8	Leydig cells: 100.1	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	HBEC3-KT: 5.0;HEL: 4.4;U-2 OS: 8.6	Not detected	Not detected			Not detected	Not detected			HPA056833	Enhanced		Approved	Vesicles						Vesicles		HPA056833: AB_2683252	unprognostic (2.78e-1)	unprognostic (6.61e-3)	unprognostic (1.03e-1)	unprognostic (5.76e-2)	unprognostic (1.15e-1)	unprognostic (1.55e-1)	unprognostic (3.08e-2)	unprognostic (6.15e-2)	unprognostic (1.74e-1)	unprognostic (5.13e-2)	unprognostic (3.26e-4)	unprognostic (3.45e-1)	unprognostic (5.48e-8)	unprognostic (8.47e-3)	unprognostic (1.15e-1)	unprognostic (7.24e-2)	unprognostic (3.11e-2)	0.5	0.4	1	0.5	1	0.4	0.5	0.5	0.9	0.8	0.5	0.5	0.5	0.4	0.5	0.5	0.5	1.3	0.5	0.5	1.7	0.5	1	6.3	0.5	0.5	1.6	0.5	0.5	1.3	0.4	0.5	0.5	0.5	0.8	0.4	0.5	0.5	0.5	0.5	0.5	1.1	0.5	1.9	0.5	0.4	41.9	0.5	0.5	4.5	0.5	0.5	0.5	0.5	0	0.3	0	0	0	0	2.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0	0	4.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.2	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	8.6	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	2.1	1	1	0.5	0.9	1.7	0.5	1.6	0.5	0.5	0.5	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	3.5	0.4	0.3	0	0.4	0	0.2	0.1	0	1.6	0	0	1.7	0	0	7.8	100.1	0	0	0	0.2	0.5	0.1	0	12	0	0.2	0	0.5	0.3	1.9	0.3	0.1	0	0.2	0	Leydig cells
LPAR4	GPR23, LPA4, P2RY9, P2Y5-LIKE, P2Y9	ENSG00000147145	Lysophosphatidic acid receptor 4	Q99677	X	78747709-78757094	G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		brain: 15.8;ovary: 10.0	Cell type enriched	Detected in some	7	Leydig cells: 18.7	Cancer enhanced	Detected in single		glioma: 0.9	Low region specificity	Detected in all			Cell type enriched	Detected in single	12	basophil: 7.4	Lineage enriched	Detected in single	12	granulocytes: 7.4	Cell line enhanced	Detected in some		AF22: 10.3;NTERA-2: 16.7;RH-30: 7.0;SuSa: 4.0;U-937: 4.0	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA046563, HPA054951, HPA055571	Uncertain		Supported	Nuclear bodies,Vesicles,Plasma membrane						Plasma membrane	Nuclear bodies, Vesicles	HPA046563: AB_2732529, HPA054951: AB_2682646, HPA055571: AB_2682853	unprognostic (1.62e-1)	unprognostic (3.53e-1)	unprognostic (1.58e-1)	unprognostic (5.81e-4)	unprognostic (3.12e-2)	unprognostic (4.85e-3)	unprognostic (2.81e-1)	unprognostic (2.57e-1)	unprognostic (6.75e-2)	unprognostic (6.73e-2)	unprognostic (8.91e-2)	unprognostic (4.86e-4)	unprognostic (2.99e-5)	unprognostic (9.27e-3)	unprognostic (1.00e-1)	unprognostic (3.58e-2)	unprognostic (6.03e-3)	1.5	0.2	6	1	2.1	0.6	2	4.9	3.7	1.8	0.9	7.4	0.7	0.2	2.9	0.8	1.8	1.1	2.1	1.9	15.8	1.4	0.3	0.3	0.3	0.2	2.4	4	10	0.7	0.1	0.7	0.2	3.6	0.6	1.2	0.5	1	1.6	0.2	1.6	0.9	1.3	3.8	0.4	1.5	0.8	5.6	0	0.6	0.8	1.2	1.4	0.9	0	0.5	7.4	0	0	0	0.1	0	0	10.3	0	0	0	0	0	0.6	1.1	1.4	0	0	0	0.1	0.1	0.6	0	0.7	0	1.3	0	0	0.2	0	0	0	1.1	0	0.5	0	0.3	0	0	0	0.8	0	0.1	2.3	0	0.5	1.8	16.7	0	0.2	0.9	7	0	0.3	0	0	0	0	0	0.1	4	0	2.7	0	0	0.2	0	0.7	1.4	0	0.7	0.7	4	1.6	7.4	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0.1	6	2.1	4.9	3.5	15.8	1.4	2.4	4	3.6	5.6	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.2	0.1	0	0	0.1	0	0	0	0	0	18.7	0	1.7	1	0	0.5	0	0	2.5	0	0	0	0.3	0	0	0.4	0	0	0	0.1	Leydig cells
STAR	StAR, STARD1	ENSG00000147465	Steroidogenic acute regulatory protein	P49675	8	38143649-38151265	Disease related genes, Predicted intracellular proteins	Lipid transport, Steroidogenesis, Transport		Congenital adrenal hyperplasia, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	7	adrenal gland: 311.3;ovary: 124.6	Cell type enriched	Detected in some	5	Leydig cells: 46.3	Cancer enhanced	Detected in some		testis cancer: 3.0	Region enriched	Detected in some	8	basal ganglia: 10.6	Cell type enriched	Detected in single	11	basophil: 5.7	Lineage enriched	Detected in single	11	granulocytes: 5.7	Cell line enriched	Detected in some	5	K-562: 101.9	Low region specificity	Detected in all			Not detected	Not detected			HPA023644, HPA027318, CAB032598	Enhanced											CAB032598: AB_2115937, HPA023644: AB_10598916, HPA027318: AB_10601574	unprognostic (1.60e-4)	unprognostic (3.20e-2)	unprognostic (9.17e-2)	unprognostic (3.28e-2)	unprognostic (9.22e-2)	unprognostic (1.32e-3)	unprognostic (1.96e-2)	unprognostic (2.12e-5)	unprognostic (3.30e-2)	unprognostic (2.36e-1)	unprognostic (1.77e-3)	unprognostic (6.65e-2)	unprognostic (4.75e-9)	unprognostic (1.58e-1)	unprognostic (1.33e-1)	unprognostic (9.48e-2)	unprognostic (6.16e-2)	0.2	311.3	0.5	0.3	10.6	0.3	0	0	1	0	0	11.6	0	0	0.1	0.8	0.2	0.4	0	0.1	0.3	0.5	0	0	0	0.3	0.2	0.9	124.6	0	0	0.2	0	1.2	0	0	0	0.1	0	0	0.5	0	0.2	0.4	0	0	29.5	0.1	0	0	0	0.2	0	0.2	0.3	0.1	5.7	0.1	0	0.5	0.1	0	0	0.2	0	0	0.9	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	21.9	0.1	1.3	0.3	1	0	3.5	0	0	0	0.2	0	0	101.9	0	0	0	0	12	2.8	0	0	0	0	0	0	0	0.2	0.2	0	0	0	0	0	12.2	0.3	0	0	0	0	0	0	0	0	2.5	0	5.7	0.1	0.4	0	0	0	0	0	0	0.1	0.3	0	0.2	0.3	0	0	0	0.5	0.1	0.5	10.6	0	1	0.3	0.5	0.2	0.9	1.2	0.1	0	0	0	0.6	8.4	1.2	0.4	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0.2	0.2	0	0	0.2	0	0	0	0	5.6	46.3	0	3.3	0	0	0.5	0.1	0	3.9	0	0.7	0	0.2	1.4	0.7	9.8	0.1	0	0	0.1	Leydig cells
SCARA5	FLJ23907, MGC45780, NET33	ENSG00000168079	Scavenger receptor class A member 5	Q6ZMJ2	8	27869882-27992727	Predicted intracellular proteins, Predicted membrane proteins	Ion transport, Iron transport, Transport	Receptor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in some	9	Leydig cells: 125.7	Low cancer specificity	Detected in many			Low region specificity	Detected in some			Cell type enriched	Detected in single	117	plasmacytoid DC: 17.3	Lineage enriched	Detected in single	173	dendritic cells: 17.3	Cell line enriched	Detected in some	20	ASC diff: 73.9	Low region specificity	Detected in some			Low region specificity	Detected in many			HPA024661	Approved								1500000			HPA024661: AB_1853902	unprognostic (2.76e-2)	unprognostic (7.20e-3)	unprognostic (1.44e-2)	unprognostic (3.53e-2)	unprognostic (2.34e-2)	unprognostic (4.62e-2)	unprognostic (2.01e-1)	unprognostic (2.15e-1)	unprognostic (9.13e-2)	unprognostic (2.40e-1)	unprognostic (4.21e-2)	unprognostic (1.10e-1)	unprognostic (7.09e-6)	unprognostic (3.48e-2)	unprognostic (2.29e-1)	unprognostic (7.62e-2)	unprognostic (1.97e-1)	26.9	1.7	0.7	4.6	0.5	0	18.5	0.6	1.1	9.2	17.3	0.4	14.3	3.8	2.3	31	23.6	8.8	13.5	42.4	0.7	0.1	0.8	1.6	8.2	3.6	2.8	0.6	5.2	2.6	0	2.3	18.5	4.1	9.8	16.4	34.3	11.4	3.6	6.1	13	9.8	37.2	1.4	1.1	11	12.3	0.3	0.5	9.1	15.9	2.2	28.4	54.6	0	17.3	0	0	0	0	0.1	0	2.4	0	0	73.9	3.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.4	0	0	0	0	3.5	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0.2	0	0	0	0	0	0	0	0.8	0.1	0	0	0	0	0	2.1	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	17.3	0	0.1	0.7	0.5	0.6	1.1	0.7	0.1	2.8	0.6	4.1	0.3	0	0	0	0	5.8	0	3.1	0	0	0	0	0	0.1	0	0	1.3	2.9	0	0	0	0.3	13.4	0.1	0	0	0.3	0	0	0	0	2.7	125.7	0.3	6.8	0	0	2	0	0	10.6	0	0	0	2.7	0.9	0.9	5.3	0.1	0	0	0.1	Leydig cells
NPY2R		ENSG00000185149	Neuropeptide Y receptor Y2	P49146	4	155208629-155217078	G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 10.2;breast: 4.1	Cell type enriched	Detected in some	11	Leydig cells: 19.5	Cancer enhanced	Detected in single		glioma: 1.0	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A549: 2.6;ASC diff: 3.6;HSkMC: 1.7;SH-SY5Y: 12.9	Group enriched	Detected in many	5	amygdala: 13.5;basal ganglia: 13.1;hippocampal formation: 51.2;hypothalamus: 27.7	Region enriched	Detected in all	5	hippocampal formation: 19.7														unprognostic (7.14e-2)				unprognostic (4.36e-3)					unprognostic (7.08e-2)		unprognostic (5.50e-2)			unprognostic (9.35e-2)			0.8	1.1	3.4	1.3	6.9	0.1	4.1	0.1	8.6	0.4	2.7	1.8	0	1.1	0.2	0.4	0.2	0.5	0.2	0.7	7.3	5.5	0.3	0.1	0.2	0.2	0.8	0	0.4	0.1	0.1	0.2	0.2	7.8	0.5	2.8	0.2	2	0.2	0.1	0.5	1.5	0.6	10.2	0.6	0.3	2.5	0	0	0.1	0	0.3	0.2	0.1	0	0	0	0	0	0	0	0	2.6	0.2	0	3.6	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	12.9	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.4	6.9	0.1	8.6	7.3	5.5	0.8	0	7.8	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	19.5	0	0	0	0	0	0	0	0.4	0	0	0	0	0.1	0.4	0	0	0	0	0	Leydig cells
SPRR2B		ENSG00000196805	Small proline rich protein 2B	P35325	1	153070224-153070840	Predicted intracellular proteins	Keratinization			Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	5	esophagus: 22.3;lymphoid tissue: 11.7;skin 1: 11.2	Cell type enriched	Detected in single	58	Leydig cells: 5.8	Cancer enriched	Detected in many	5	head and neck cancer: 77.2					Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HL-60: 1.7;SiHa: 1.3;U-2197: 1.2																							unprognostic (1.52e-1)				unprognostic (1.44e-2)			unprognostic (3.62e-1)									0	0	0	0	0	0	0	0	0	1.2	0			0	0	0	22.3	0	0	0	0	0	0	0	0	0	0		0.4	0	0	0	0		0	0		3	0	0	11.2	0	0	0	0	0	3.2			0		11.7	0	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0.4	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Leydig cells
VIT		ENSG00000205221	Vitrin	Q6UXI7	2	36696690-36814792	Predicted intracellular proteins, Predicted secreted proteins	Neurogenesis			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in some	5	Leydig cells: 106.7	Low cancer specificity	Detected in some			Low region specificity	Detected in some			Group enriched	Detected in some	8	gdT-cell: 5.3;memory CD8 T-cell: 2.3;naive CD8 T-cell: 3.4	Lineage enriched	Detected in single	11	T-cells: 5.3	Cell line enhanced	Detected in some		ASC diff: 13.5;ASC TERT1: 26.5;BJ: 12.7;fHDF/TERT166: 43.0;SuSa: 25.7;THP-1: 13.5	Low region specificity	Detected in many			Low region specificity	Detected in many								Secreted to extracellular matrix				120000				unprognostic (5.34e-4)	unprognostic (4.49e-2)	unprognostic (1.49e-2)	unprognostic (1.20e-1)	unprognostic (7.78e-3)	unprognostic (8.32e-2)		unprognostic (1.81e-1)	unprognostic (3.08e-1)	unprognostic (3.35e-1)	unprognostic (1.64e-1)	unprognostic (2.63e-2)	unprognostic (3.66e-6)	unprognostic (2.09e-1)	unprognostic (2.01e-1)	unprognostic (3.62e-3)	unprognostic (1.41e-2)	25.5	1.2	0.2	0.6	0.4	0.9	10.3	2.5	1	7.4	2.1	0.3	6.3	0.6	1.9	11.4	17.1	5	2.7	14.2	0.2	0.1	0.5	0.2	1.2	2.3	3.4	0.7	30	2.2	1	2	6.8	1	15.3	1.7	18.1	7.8	2.9	11.6	8.3	1.5	20.5	5.1	0.3	3.4	10.5	0	0	7.9	22	3.9	21.4	10.9	0	0	0	0.1	0.4	5.3	1.1	0	0	0	0	13.5	26.5	0	12.7	3	4.1	1.7	0	0	0	0	43	0	0	2.4	0	2.7	0	0	0	0.9	0	0	0	0	0.4	0	0	0	1.3	0.6	0	0	0	1	0	0	0.5	0	0	0	0	0	0	0.1	0	0	0	0.1	0.3	0	25.7	0	13.5	0	0	0	0	0	0	0	0	0.1	0.9	0.9	0	0	0	5.3	0	0	0	0.2	2.3	0	0	0	3.4	0	0.4	0.1	0	0	1.1	0.2	0.4	2.5	0.6	0.2	0.1	3.4	0.7	1	0	0	0	0	1	3.8	0	3.6	0	0	0	0	0	8.7	0	0	1.1	0.3	0	0	0	6.9	7.4	0.1	0	0	1	0	0	0.6	0	0.2	106.7	0	6.8	0	0.3	0	0	0	21.9	0	0	6.5	2.1	1.1	0.2	3	3.5	0	0	0.1	Leydig cells
IGF2		ENSG00000284779	Insulin like growth factor 2		11	2129112-2158658	Predicted intracellular proteins, RAS pathway related proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in some	8	liver: 24.1	Cell type enriched	Detected in many	5	Leydig cells: 2784.7									Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CACO-2: 1.2;RH-30: 3.3														Intracellular and membrane																									1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	24.1	0	0	0	0	0	0	0	2.8	1.2	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	1.4	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	1.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.3	0	0	0	0.3	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	3.3	0	0	0	0	0.8	0.3	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											3	1.9	0	0.6	4.7	0	0	2.5	1.4	1.2	3.5	0	0	0	0	9.1	11.3	0	0	0	0	3.9	0.3	0	350.3	0	0	0	38.1	8.5	19.9	2784.7	1.7	3.3	0	0	0.1	0	0	605.3	0	0.3	64.7	7.3	3.2	4.3	3.6	0	0	0	0.1	Leydig cells
